{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:25:42Z","timestamp":1754195142670},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2012,5,12]],"date-time":"2012-05-12T00:00:00Z","timestamp":1336780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00246-012-0329-1","type":"journal-article","created":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T09:34:29Z","timestamp":1336728869000},"page":"1343-1347","source":"Crossref","is-referenced-by-count":4,"title":["Increased \u03b11-Antitrypsin Levels in Acute-Phase Kawasaki Disease as Shown by SELDI-TOF MS Analysis"],"prefix":"10.1007","volume":"33","author":[{"given":"Takahiro","family":"Kanai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirohiko","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ritei","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takane","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariko Y.","family":"Momoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,12]]},"reference":[{"key":"329_CR1","doi-asserted-by":"crossref","first-page":"5837","DOI":"10.4049\/jimmunol.174.9.5837","volume":"174","author":"J Abe","year":"2005","unstructured":"Abe J, Jibiki T, Noma S, Nakajima T, Saito H, Terai M (2005) Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease. J Immunol 174:5837\u20135845","journal-title":"J Immunol"},{"key":"329_CR2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","volume":"1","author":"NL Anderson","year":"2002","unstructured":"Anderson NL, Anderson NG (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1:845\u2013867","journal-title":"Mol Cell Proteomics"},{"key":"329_CR3","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1165\/rcmb.F250","volume":"27","author":"M Brantly","year":"2002","unstructured":"Brantly M (2002) Alpha1-antitrypsin: not just an antiprotease: extending the half-life of a natural anti-inflammatory molecule by conjugation with polyethylene glycol. Am J Respir Cell Mol Biol 27:652\u2013654","journal-title":"Am J Respir Cell Mol Biol"},{"key":"329_CR4","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1442-200X.1991.tb02612.x","volume":"33","author":"K Harada","year":"1991","unstructured":"Harada K (1991) Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 33:805\u2013810","journal-title":"Acta Paediatr Jpn"},{"key":"329_CR5","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1442-200X.2003.01766.x","volume":"45","author":"M Iino","year":"2003","unstructured":"Iino M, Shiraishi H, Igarashi H, Honma Y, Momoi MY (2003) Case of Kawasaki disease in NICU. Pediatr Int 45:580\u2013583","journal-title":"Pediatr Int"},{"key":"329_CR6","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1442-200X.1987.tb00033.x","volume":"29","author":"Y Inamo","year":"1987","unstructured":"Inamo Y, Harada K, Okuni M, Kimoto K, Takeuchi S, Sakurabayashi I (1987) Immunoreactive polymorphonuclear leukocyte elastase in complex with alpha 1-antitrypsin in Kawasaki disease. Acta Paediatr Jpn 29:202\u2013205","journal-title":"Acta Paediatr Jpn"},{"key":"329_CR7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1006\/bbrc.2002.6678","volume":"292","author":"HJ Issaq","year":"2002","unstructured":"Issaq HJ, Veenstra TD, Conrads TP, Felschow D (2002) The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. Biochem Biophys Res Commun 292:587\u2013592","journal-title":"Biochem Biophys Res Commun"},{"key":"329_CR8","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00467-006-0165-8","volume":"21","author":"M Khurana","year":"2006","unstructured":"Khurana M, Traum AZ, Aivado M, Wells MP, Guerrero M, Grall F et al (2006) Urine proteomic profiling of pediatric nephrotic syndrome. Pediatr Nephrol 21:1257\u20131265","journal-title":"Pediatr Nephrol"},{"key":"329_CR9","doi-asserted-by":"crossref","first-page":"R261","DOI":"10.1186\/gb-2007-8-12-r261","volume":"8","author":"SJ Popper","year":"2007","unstructured":"Popper SJ, Shimizu C, Shike H, Kanegaye JT, Newburger JW, Sundel RP et al (2007) Gene-expression patterns reveal underlying biological processes in Kawasaki disease. Genome Biol 8:R261","journal-title":"Genome Biol"},{"key":"329_CR10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF00441650","volume":"140","author":"CH Rieger","year":"1983","unstructured":"Rieger CH, Kawasaki T, Yanase Y, Pollack U (1983) Complement and protease inhibitors in the mucocutaneous lymph node syndrome. Eur J Pediatr 140:92\u201397","journal-title":"Eur J Pediatr"},{"key":"329_CR11","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.prp.2004.03.002","volume":"200","author":"C Rocken","year":"2004","unstructured":"Rocken C, Ebert MP, Roessner A (2004) Proteomics in pathology, research and practice. Pathol Res Pract 200:69\u201382","journal-title":"Pathol Res Pract"},{"key":"329_CR12","first-page":"195","volume":"6","author":"H Shiraishi","year":"2007","unstructured":"Shiraishi H, Iino M, Hoshina M, Ichihashi K, Momoi MY (2007) Intravenous immunoglobulin 1\u00a0g\/kg as the initial treatment for Kawasaki disease. World J Pediatr 6:195\u2013199","journal-title":"World J Pediatr"},{"key":"329_CR13","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11926-002-0053-6","volume":"4","author":"RP Sundel","year":"2002","unstructured":"Sundel RP (2002) Update on the treatment of Kawasaki disease in childhood. Curr Rheumatol Rep 4:474\u2013482","journal-title":"Curr Rheumatol Rep"},{"key":"329_CR14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1442-200x.2005.02049.x","volume":"47","author":"K Takahashi","year":"2005","unstructured":"Takahashi K, Oharaseki T, Naoe S, Wakayama M, Yokouchi Y (2005) Neutrophilic involvement in the damage to coronary arteries in acute stage of Kawasaki disease. Pediatr Int 47:305\u2013310","journal-title":"Pediatr Int"},{"issue":"Suppl 1","key":"329_CR15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2249.2011.04361.x","volume":"164","author":"K Takahashi","year":"2011","unstructured":"Takahashi K, Oharaseki T, Yokouchi Y (2011) Pathogenesis of Kawasaki disease. Clin Exp Immunol 164(Suppl 1):20\u201322","journal-title":"Clin Exp Immunol"},{"key":"329_CR16","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1086\/314600","volume":"179","author":"S Takeshita","year":"1999","unstructured":"Takeshita S, Nakatani K, Kawase H, Seki S, Yamamoto M, Sekine I et al (1999) The role of bacterial lipopolysaccharide-bound neutrophils in the pathogenesis of Kawasaki disease. J Infect Dis 179:508\u2013512","journal-title":"J Infect Dis"},{"key":"329_CR17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1367-5931(01)00282-4","volume":"6","author":"SR Weinberger","year":"2002","unstructured":"Weinberger SR, Dalmasso EA, Fung ET (2002) Current achievements using ProteinChip array technology. Curr Opin Chem Biol 6:86\u201391","journal-title":"Curr Opin Chem Biol"},{"key":"329_CR18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1053\/ejvs.2001.1303","volume":"21","author":"KA Wilson","year":"2001","unstructured":"Wilson KA, Lindholt JS, Hoskins PR, Heickendorff L, Vammen S, Bradbury AW (2001) The relationship between abdominal aortic aneurysm distensibility and serum markers of elastin and collagen metabolism. Eur J Vasc Endovasc Surg 21:175\u2013178","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"329_CR19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/315332","volume":"181","author":"M Zaitsu","year":"2000","unstructured":"Zaitsu M, Hamasaki Y, Tashiro K, Matsuo M, Ichimaru T, Fujita I, Tasaki H et al (2000) Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease. J Infect Dis 181:1101\u20131109","journal-title":"J Infect Dis"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-012-0329-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00246-012-0329-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-012-0329-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T14:18:46Z","timestamp":1558707526000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00246-012-0329-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,12]]},"references-count":19,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["329"],"URL":"https:\/\/doi.org\/10.1007\/s00246-012-0329-1","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,12]]}}}